Immunological and Polyfunctional T Cell Profiling Following Therapy With DPX-Survivac as a Predictive Tool of Vaccine Efficacy

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Vaccine Efficacy and T Helper Cell Differentiation Change With Aging

Oncotarget
Oncology
2016English

SPIReL: PHASE 2 STUDY DPX-SURVIVAC WITH INTERMITTENT LOW DOSE CYCLOPHOSPHAMIDE AND PEMBROLIZUMAB IN PATIENTS WITH RECURRENT/REFRACTORY DIFFUSE LARGE B-Cell LYMPHOMA

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Hepatitis B Virus-Infected HepG2hNTCPCells Serve as a Novel Immunological Tool to Analyze the Antiviral Efficacy of CD8+T CellsIn Vitro

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2015English

Proteomic Profiling Identifies Outcome-Predictive Markers in Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified

Blood advances
Hematology
2018English

Can We Improve Vaccine Efficacy by Targeting T and B Cell Repertoire Convergence?

Frontiers in Immunology
AllergyImmunology
2019English

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes

Frontiers in Oncology
Cancer ResearchOncology
2018English

T Cell Tool

Science
MultidisciplinaryPhilosophy of ScienceHistory
1996English

Outcomes of Patients With Large B‐Cell Lymphomas and Progressive Disease Following CD19‐Specific CAR T‐Cell Therapy

American Journal of Hematology
Hematology
2019English

Immunological Profiling of Obesity

Journal of Lifestyle Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy